NL194231C - Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat. - Google Patents

Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat. Download PDF

Info

Publication number
NL194231C
NL194231C NL8500417A NL8500417A NL194231C NL 194231 C NL194231 C NL 194231C NL 8500417 A NL8500417 A NL 8500417A NL 8500417 A NL8500417 A NL 8500417A NL 194231 C NL194231 C NL 194231C
Authority
NL
Netherlands
Prior art keywords
bromocriptine
capsule
capsules
hours
controlled
Prior art date
Application number
NL8500417A
Other languages
English (en)
Dutch (nl)
Other versions
NL194231B (nl
NL8500417A (nl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NL8500417A publication Critical patent/NL8500417A/nl
Publication of NL194231B publication Critical patent/NL194231B/xx
Application granted granted Critical
Publication of NL194231C publication Critical patent/NL194231C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8500417A 1984-02-29 1985-02-14 Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat. NL194231C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB8405227 1984-02-29

Publications (3)

Publication Number Publication Date
NL8500417A NL8500417A (nl) 1985-09-16
NL194231B NL194231B (nl) 2001-06-01
NL194231C true NL194231C (nl) 2001-10-02

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8500417A NL194231C (nl) 1984-02-29 1985-02-14 Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat.

Country Status (26)

Country Link
JP (1) JPS60202812A (da)
AT (1) AT387716B (da)
AU (2) AU586621B2 (da)
BE (1) BE901810A (da)
CA (1) CA1256374A (da)
CH (2) CH666406A5 (da)
DE (1) DE3505743C2 (da)
DK (1) DK175016B1 (da)
ES (1) ES8705223A1 (da)
FR (1) FR2560047B1 (da)
GB (1) GB8405227D0 (da)
GR (1) GR850506B (da)
HK (1) HK85490A (da)
HU (1) HU196121B (da)
IE (1) IE58235B1 (da)
IL (1) IL74459A (da)
IT (1) IT1199948B (da)
LU (1) LU85791A1 (da)
MX (1) MX9203626A (da)
NL (1) NL194231C (da)
NZ (1) NZ211247A (da)
PH (1) PH23266A (da)
PT (1) PT80015B (da)
SE (2) SE462259B (da)
SG (1) SG69390G (da)
ZA (1) ZA851546B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (da) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
DK86785D0 (da) 1985-02-26
MX9203626A (es) 1992-09-01
JPS60202812A (ja) 1985-10-14
PT80015B (pt) 1987-09-18
IL74459A (en) 1988-12-30
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
GB8405227D0 (en) 1984-04-04
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
FR2560047A1 (fr) 1985-08-30
CA1256374A (en) 1989-06-27
PH23266A (en) 1989-06-23
IT1199948B (it) 1989-01-05
DK86785A (da) 1985-08-30
SE8500961L (sv) 1985-08-30
HK85490A (en) 1990-10-25
IT8547703A0 (it) 1985-02-20
NL8500417A (nl) 1985-09-16
AU618599B2 (en) 1992-01-02
CH666406A5 (de) 1988-07-29
DK175016B1 (da) 2004-04-26
ZA851546B (en) 1986-10-29
IE58235B1 (en) 1993-08-11
ES8705223A1 (es) 1987-05-01
CH667009A5 (de) 1988-09-15
SE8500961D0 (sv) 1985-02-27
BE901810A (fr) 1985-08-26
AT387716B (de) 1989-03-10
AU3500689A (en) 1989-09-14
HU196121B (en) 1988-10-28
DE3505743A1 (de) 1985-08-29
IL74459A0 (en) 1985-05-31
AU3913685A (en) 1985-09-05
ATA58085A (de) 1988-08-15
HUT38254A (en) 1986-05-28
SE462259B (sv) 1990-05-28
IE850495L (en) 1985-08-29
GR850506B (da) 1985-06-28
JPH0448776B2 (da) 1992-08-07
SG69390G (en) 1990-10-26
DE3505743C2 (de) 1995-02-16
AU586621B2 (en) 1989-07-20
FR2560047B1 (fr) 1988-01-15
NZ211247A (en) 1989-02-24
LU85791A1 (fr) 1985-12-11

Similar Documents

Publication Publication Date Title
US5624677A (en) Controlled release of drugs delivered by sublingual or buccal administration
TWI241911B (en) Sustained release ranolazine formulations
CA2289260C (en) Controlled release of drugs delivered by sublingual or buccal administration
US10821118B2 (en) Oral transmucosal drug delivery system
US7741374B1 (en) Methods of use of fenofibric acid
TWI262800B (en) Dosage form of sodium ibuprofen
GB2154874A (en) Bromocriptine compositions
PT85128B (pt) Processo para a preparacao de composicoes farmaceuticas contendo, como ingrediente activo, 4-(1-metil-4-piperidilideno)-4h-benzo-{4,5}ciclohepta{1,2-b}tiofeno--10(9h)-ona
NL194231C (nl) Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat.
DK2802311T3 (da) Sublingual farmaceutisk sammensætning indeholdende et antihistaminmiddel og fremgangsmåde til fremstilling deraf
NL8600161A (nl) Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
KR920008817B1 (ko) 조절된 방출성(서방성) 약학적 제제의 제조방법.
KR102236650B1 (ko) 아세클로페낙을 포함하는 약학조성물 및 이의 제조방법
PL194595B1 (pl) Preparat tiagabiny o przedłużonym uwalnianiu orazjego zastosowanie
JP2521463B2 (ja) 塩酸ジラゼプ持効性錠剤
JPH11501026A (ja) イソソルビド−５−モノナイトレートの使用

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20050214